Filter
2396
Filtered Results: 2396
Text search:
clinical
specimens
Featured
Recommendations
316
New Publications
637
Language
Document type
No document type
1263
Guidelines
480
Studies & Reports
338
Manuals
130
Strategic & Response Plan
77
Fact sheets
48
Training Material
30
Situation Updates
18
Resource Platforms
4
Infographics
4
Brochures
2
Online Courses
1
Videos
1
Countries / Regions
India
148
Global
75
South Africa
70
Kenya
69
Nigeria
56
Liberia
53
Sierra Leone
52
Western and Central Europe
51
Tanzania
45
Ethiopia
43
Uganda
42
Africa
37
Ghana
36
Zambia
36
Rwanda
35
Latin America and the Carribbean
33
Malawi
28
Nepal
26
Namibia
24
Philippines
22
Bangladesh
22
Congo, Democratic Republic of
21
West and Central Africa
21
Eastern Europe
20
Zimbabwe
17
East and Southern Africa
17
Lesotho
15
South–East Asia Region
15
Mozambique
14
Russia
14
Indonesia
14
Middle East and North Africa
13
Cambodia
12
Guinea
11
Eastern Europe and Central Asia
11
Brazil
11
Botswana
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
Germany
10
Ukraine
9
Madagascar
9
Syria
8
Senegal
8
Cameroon
7
South Sudan
7
Burkina Faso
6
Western Pacific Region
6
Tajikistan
5
Colombia
5
USA
5
Asia
5
Venezuela
5
Spain
5
Angola
5
Pakistan
5
Thailand
3
China
3
Afghanistan
3
Peru
3
Haiti
3
North America
3
France
3
Côte d’Ivoire / Ivory Coast
3
Vietnam
3
Iraq
3
Turkey
2
Benin
2
Gambia
2
Iran
2
Burundi
2
Morocco
2
Jordan
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Southern Africa
2
Lebanon
2
Sri Lanka
2
Yemen
2
Palestine
2
Georgia
2
Mali
2
Somalia
2
Ecuador
2
North Macedonia
1
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Albania
1
Singapore
1
Laos
1
Uzbekistan
1
Qatar
1
Italy
1
Guinea-Bissau
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Argentina
1
Papua New Guinea
1
Moldova
1
Sudan
1
Romania
1
Greece
1
Central African Republic
1
Chad
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
908
Clinical Guidelines
325
Public Health
104
Pharmacy & Technologies
87
Key Resources
74
Women & Child Health
50
Capacity Building
28
Toolboxes
COVID-19
251
TB
244
Rapid Response
191
NTDs
188
AMR
180
HIV
140
Ebola & Marburg
115
Planetary Health
54
Pharmacy
42
Zika
40
Mental Health
39
Caregiver
30
Cholera
22
Polio
17
Refugee
16
Natural Hazards
16
NCDs
16
Conflict
12
Global Health Education
10
Specific Hazards
9
Health Financing Toolbox
8
Malaria
7
Disability
5
Social Ethics
1
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat...
Snakebite envenoming is a potentially life-threatening disease that typically results from the injection of a mixture of different toxins (“venom”) following the bite of a venomous snake. Envenoming can also be caused by venom being sprayed into a person’s eyes by certain species of snakes tha...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decisions about appropriate treatment for specific clinical...
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
"Achieving, maintaining and improving accuracy, timeliness and reliability are major challenges for health laboratories. Countries worldwide committed themselves to build national capacities for the detection of, and response to, public health events of international concern when they decided to eng...
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati...
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases.
The List is divid...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
La evolución de los acontecimientos y el esfuerzo conjunto de la comunidad científica mundial, hangeneradogran cantidad de información que se modificarápidamente con nuevas evidencias. Este documento pretende hacer unresumen analítico de la evidencia científica dispo...
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the MUL...
